Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor AntagonistXavier Ligneau, Joseph E. Schwartz, Jian‐Sheng Lin et al.|Journal of Pharmacology and Experimental Therapeutics|1998Cited by 240
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical PharmacologyXavier Ligneau, Schwartz Jc, J.-C. Camelin et al.|Journal of Pharmacology and Experimental Therapeutics|2006Cited by 234
Distinct pharmacology of rat and human histamine H<sub>3</sub> receptors: role of two amino acids in the third transmembrane domainXavier Ligneau, Séverine Morisset‐Lopez, J Tardivel‐Lacombe et al.|British Journal of Pharmacology|2000Cited by 149
Protean agonism at histamine H <sub>3</sub> receptors <i>in vitro</i> and <i>in vivo</i>Florence Gbahou, Jean‐Michel Arrang, A. Rouleau et al.|Proceedings of the National Academy of Sciences|2003Cited by 142
[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.Xavier Ligneau, Joseph E. Schwartz, M. Garbarg et al.|Journal of Pharmacology and Experimental Therapeutics|1994Cited by 132